Cyber Resilience

CVE-2023-33365

High

Published: 03 August 2023

Published
03 August 2023
Modified
21 November 2024
KEV Added
Patch
CVSS Score v3.1 7.5 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
EPSS Score 0.0048 65.5th percentile
Risk Priority 15 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2023-33365 is a high-severity Path Traversal (CWE-22) vulnerability in Supremainc Biostar 2. Its CVSS base score is 7.5 (High).

Operationally, ranked in the top 34.5% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

supremainc
biostar 2
≤ 2.9.1

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-22

Validates pathnames and filenames to prevent traversal outside intended directories.

References